Evidence map›Paper›PMID 26563344›Full record

ArticleScientific reports2015

Activin A/BMP2 chimera AB235 drives efficient redifferentiation of long term cultured autologous chondrocytes.

G Jiménez, E López-Ruiz, W Kwiatkowski, E Montañez, F Arrebola, E Carrillo, P C Gray, J C Izpisua Belmonte, S Choe, M Perán and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Bioactive-RichBiomedicines · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

G JiménezBiopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, University of Granada, Granada E-18100, Spain.
E López-RuizDepartment of Health Sciences, University of Jaén, Jaén E-23071, Spain.
W KwiatkowskiStructural Biology Laboratory, Salk Institute for Biological Studies, La Jolla CA 92037, California, USA.
E MontañezDepartment of Orthopedic Surgery and Traumatology, Virgen de la Victoria University Hospital, Málaga, Spain.
F ArrebolaDepartment of Histology, Faculty of Medicine, University of Granada, E-18071 Granada, Spain.
E CarrilloBiopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, University of Granada, Granada E-18100, Spain.
P C GrayClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla CA 92037, California, USA.
J C Izpisua BelmonteGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla CA 92037, California, USA.
S ChoeStructural Biology Laboratory, Salk Institute for Biological Studies, La Jolla CA 92037, California, USA.
M PeránDepartment of Health Sciences, University of Jaén, Jaén E-23071, Spain.
J A MarchalBiopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, University of Granada, Granada E-18100, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autologous chondrocyte implantation (ACI) depends on the quality and quantity of implanted cells and is hindered by the fact that chondrocytes cultured for long periods of time undergo dedifferentiation. Here we have developed a reproducible and efficient chondrogenic protocol to redifferentiate chondrocytes isolated from osteoarthritis (OA) patients. We used morphological, histological and immunological analysis together with a RT-PCR detection of collagen I and collagen II gene expression to show that chondrocytes isolated from articular cartilage biopsies of patients and subjected to long-term culture undergo dedifferentiation and that these cells can be redifferentiated following treatment with the chimeric Activin A/BMP2 ligand AB235. Examination of AB235-treated cell pellets in both in vitro and in vivo experiments revealed that redifferentiated chondrocytes synthesized a cartilage-specific extracellular matrix (ECM), primarily consisting of vertically-orientated collagen fibres and cartilage-specific proteoglycans. AB235-treated cell pellets also integrated into the surrounding subcutaneous tissue following transplantation in mice as demonstrated by their dramatic increase in size while non-treated control pellets disintegrated upon transplantation. Thus, our findings describe an effective protocol for the promotion of redifferentiation of autologous chondrocytes obtained from OA patients and the formation of a cartilage-like ECM that can integrate into the surrounding tissue in vivo.

Indexed as

Cell DifferentiationActivinsAgedAnimalsBone Morphogenetic Protein 2Cartilage, ArticularChondrocytesCollagenExtracellular MatrixFemaleGene ExpressionHumansImmunohistochemistryLigandsMaleMiceactivin AActivinsBMP2 protein, humanBone Morphogenetic Protein 2CollagenLigandsProteoglycans

Identifiers

PMID26563344
PMCPMC4643338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.